AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28695570
Drug: Single low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single low dose of primaquine added to DHA-piperaquine treatment
Trial: 25255776
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine treatment
Trial: 24708031
Drug: Tiotropium (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (18 μg once daily)
Trial: 22727160
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 μg twice daily)
Trial: 10730908
Drug: Terbinafine 250
RxNorm normalized name: terbinafine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 250 mg/day for 12 weeks (T12)
Trial: 10730908
Drug: Terbinafine 250
RxNorm normalized name: terbinafine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 250 mg/day for 16 weeks (T16)
Trial: 10730908
Drug: Itraconazole 400
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole 400 mg/day for 1 week in every 4 weeks for 12 weeks (I3)
Trial: 10730908
Drug: Itraconazole 400
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole 400 mg/day for 1 week in every 4 weeks for 16 weeks (I4)
Trial: 12959310
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ramipril 2.5 mg and felodipine ER 5 mg
Trial: 3303792
Drug: Methimazole 10
RxNorm normalized name: methimazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole 10 mg
Trial: 3303792
Drug: Methimazole 40
RxNorm normalized name: methimazole 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole 40 mg
Trial: 2524203
Drug: Thyroid hormone
RxNorm normalized name: Thyroid hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid hormone supplementation
Trial: 28088207
Drug: Intra-articular injection
RxNorm normalized name: PHOSPHORUS P-32 5 mCi in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injection (specifics not provided)
Trial: 26602093
Drug: Telephone Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone Cognitive Behavioral Therapy (tCBT) with motivational interviewing techniques
Trial: 24051942
Drug: Metformin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (3 g)
Trial: 24051942
Drug: Metformin (1.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1.7 g), myo-inositol, and alpha-lipoic acid
Trial: 12659599
Drug: Atorvastatin 10-20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10-20 mg/d
Trial: 12659599
Drug: Simvastatin 10-20
RxNorm normalized name: ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Simvastatin 10-20 mg/d
Trial: 1705386
Drug: Sotalol 640
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 640 mg/day
Trial: 2428852
Drug: Sotalol (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (both doses)
Trial: 30567497
Drug: Checklist intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Checklist intervention for antihypertensive medication initiation
Trial: 17412473
Drug: Flupentixol (4-12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupentixol (4-12 mg/d)
Trial: 17412473
Drug: Risperidone (2-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (2-6 mg/d)
Trial: 10503165
Drug: Tamsulosin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.2 mg once daily)
Trial: 10503165
Drug: Terazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (2 mg once daily)
Trial: 2683541
Drug: Intrapleural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural bupivacaine (bolus 20 ml followed by 10 ml/h)
Trial: 2683541
Drug: Epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bupivacaine (bolus 9 ml followed by 5 ml/h)
Trial: 26663024
Drug: Cortisol geometric
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol geometric means (nmol/l) for women with ≤5.5 hot flashes per day, N = 103
Trial: 26663024
Drug: Cortisol geometric
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol geometric means (nmol/l) for women with >5.5-8.8 hot flashes per day, N = 103
Trial: 26663024
Drug: Cortisol geometric
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol geometric means (nmol/l) for women with >8.8 hot flashes per day, N = 100
Trial: 26663024
Drug: Cortisol geometric
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol geometric means (nmol/l) for all women
Trial: 25037988
Drug: Interruption group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interruption group (single aspirin treatment after thienopyridine interruption)
Trial: 22952176
Drug: Meat (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meat (30 to 45 g daily)
Trial: 18936474
Drug: Vandetanib monotherapy
RxNorm normalized name: Vandetanib
DrugBank: Vandetanib (DB05294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vandetanib monotherapy
Trial: 18058066
Drug: Sustained inflation
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained inflation of the intrarectal balloon with 30 and 60 mL air
Trial: 18058066
Drug: Rapid inflation/deflation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid inflation/deflation of the intrarectal balloon with 30 and 60 mL air
Trial: 1855083
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Vincristine (4 mg/m2), TBI (1200 cGy), Cyclophosphamide (3600 mg/m2) as standard conditioning regimen before transplant
Trial: 6340878
Drug: sulphinpyrazone, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulphinpyrazone, 4 x 200 mg daily for 7 days
Trial: 28342739
Drug: Supervised physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised physical therapy (PT)
Trial: 25741817
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (500 mg OD aspirin for 7 days)
Trial: 26700124
Drug: Low Molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Molecular Weight Heparin (LMWH) for 24 weeks
Trial: 17329466
Drug: Quetiapine (200-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (200-800 mg/day)
Trial: 16889453
Drug: Risperidone (2-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (2-8 mg/day)
Trial: 14998418
Drug: Optimization of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimization of drug prescribing
Trial: 11028832
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg tropisetron
Trial: 15100522
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate tablets
Trial: 19491652
Drug: Stavudine 30
RxNorm normalized name: stavudine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine 30 mg
Trial: 7780046
Drug: Stavudine 40
RxNorm normalized name: stavudine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine 40 mg
Trial: 16911100
Drug: Rofecoxib +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib + Paracetamol
Trial: 11209089
Drug: Cyclophosphamide (Cy)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (Cy) plus G-CSF (arm A)
Trial: 11209089
Drug: Cyclophosphamide (Cy)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (Cy) plus GM-CSF followed by G-CSF (arm C)
Trial: 9232040
Drug: Auralgan otic
RxNorm normalized name: Auralgan Otic Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auralgan otic solution (combination product of antipyrine, benzocaine, and glycerin)
Trial: 8356980
Drug: Low-dose trimethoprim-sulfamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose trimethoprim-sulfamethoxazole (TMP 40 mg, SMX 200 mg) once daily
Trial: 332262
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg hemisuccinate hydrocortisone (HSHC)
Trial: 332262
Drug: 4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg/kg hemisuccinate hydrocortisone (HSHC)
Trial: 332262
Drug: 8 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg/kg hemisuccinate hydrocortisone (HSHC)
Trial: 27778328
Drug: Isotretinoin 10
RxNorm normalized name: isotretinoin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 10 mg every other day
Trial: 27778328
Drug: Antiseborrheic topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiseborrheic topical treatment
Trial: 15477550
Drug: l-methionine 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-methionine 6 g/day in two divided doses
Trial: 29929813
Drug: IncobotulinumtoxinA (IncoA)
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: IncobotulinumtoxinA (IncoA) injection, 80–120 units, customized injection approach
Trial: 14722514
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg/d)
Trial: 10099857
Drug: Flunarizine 10
RxNorm normalized name: flunarizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine 10 mg at bedtime for 1 and 3 months
Trial: 10099857
Drug: Bromocriptine (BRC)
DrugBank: Bromocriptine (DB01200)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromocriptine (BRC) 2.5 mg
Trial: 1651201
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg.day‐1)
Trial: 29870446
Drug: Corticosteroid +
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid + lidocaine (40 mg triamcinolone acetonide plus 5 mL of 1% lidocaine)
Trial: 29870446
Drug: Lidocaine alone
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine alone (6 mL of 1% lidocaine)
Trial: 25323182
Drug: Amoxicillin +
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin + clavulanic acid (Group A)
Trial: 25323182
Drug: No antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotics (Group C)
Trial: 19777494
Drug: Treatment under
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment under per-protocol analysis
Trial: 19777494
Drug: Noncompliance by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncompliance by switching treatment
Trial: 19777494
Drug: Noncompliance by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncompliance by subjects not receiving any treatment
Trial: 17335319
Drug: Perphenazine (8-64
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perphenazine (8-64 mg/day)
Trial: 15215002
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy for 2 hours
Trial: 31923800
Drug: Matched treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched treatment
Trial: 9642894
Drug: Mismatched treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mismatched treatment
Trial: 31218531
Drug: Medication +
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication + CT
Trial: 31218531
Drug: Medication +
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication + non-active training
Trial: 31003673
Drug: Scalp acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scalp acupuncture combined with exercise therapy and conventional rehabilitation training
Trial: 23989947
Drug: Plitidepsin 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plitidepsin 2.4 mg m(‐2) combined with DTIC 800 mg m(‐2) q4wk (n = 38)
Trial: 23989947
Drug: Single-agent plitidepsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent plitidepsin 3.2 mg m(‐2) (n = 20)
Trial: 18466359
Drug: Asimadoline 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asimadoline 0.5 mg
Trial: 18331462
Drug: Asimadoline 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asimadoline 1.0 mg
Trial: 15656399
Drug: Dipyridamole (curantyl,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (curantyl, 100 mg a week)
Trial: 11895512
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol
Trial: 9703125
Drug: Topical tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tretinoin
Trial: 8198936
Drug: Imidapril 5
RxNorm normalized name: imidapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril 5 mg
Trial: 8198936
Drug: Imidapril 20
RxNorm normalized name: imidapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril 20 mg
Trial: 8181800
Drug: Imidapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril (5 mg and 20 mg)
Trial: 3371098
Drug: Single sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single sclerotherapy treatment with tetracycline at a dose of 20 mg/kg
Trial: 3371098
Drug: Two sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two sclerotherapy treatments with tetracycline
Trial: 30343531
Drug: IXEQ2W (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IXEQ2W (80 mg subcutaneous ixekizumab every 2 weeks)
Trial: 30343531
Drug: IXEQ4W (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IXEQ4W (80 mg subcutaneous ixekizumab every 4 weeks)
Trial: 29095374
Drug: Dialectical Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialectical Behavioral Therapy-Case Management (DBT-CM)
Trial: 22026392
Drug: Oral atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral atorvastatin 40 mg/day
Trial: 10952952
Drug: Combination diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination diet (rich in fruits, vegetables, and low-fat dairy products, reduced in saturated and total fat)
Trial: 8620234
Drug: Cromolyn sodium,
RxNorm normalized name: Cromolyn Sodium, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium, 20 mg four times a day for 8 weeks and 20 mg three times a day for 8 weeks
Trial: 8620234
Drug: Budesonide, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide, 500 micrograms twice a day for 8 weeks and 250 micrograms twice a day for 8 weeks
Trial: 1468164
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg three times a day for three days)
Trial: 23294774
Drug: Adaptive, dose-finding,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaptive, dose-finding, seamless phase 2/3 trial
Trial: 23294774
Drug: Drug supply
RxNorm normalized name: doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug supply management for nine treatment arms
Trial: 9890620
Drug: Malignant group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Malignant group (treated with antineoplastic agents)
Trial: 7745044
Drug: Timed intercourse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timed intercourse with cyclic, low-dose prednisolone (20 mg)
Trial: 6775301
Drug: Sustained-release nitroglycerin
RxNorm normalized name: nitroglycerin Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release nitroglycerin capsules
Trial: 17786056
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II Receptor Blockers (ARBs)
Trial: 17786056
Drug: Angiotensin-Converting Enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-Converting Enzyme (ACE) inhibitors
Trial: 28509727
Drug: Calcium Channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Channel Blockers (CCBs)
Trial: 28894283
Drug: JinqiJiangtang tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JinqiJiangtang tablets (JQJT tablets)
Trial: 25643028
Drug: Alcohol (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (target BrAC = .08 g%) in lab context
Trial: 25643028
Drug: Alcohol (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (target BrAC = .08 g%) in simulated bar context
Trial: 21115863
Drug: IV amifostine
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV amifostine (200 mg/m(2) daily for 3 minutes, 15 to 30 minutes before irradiation)
Trial: 21115863
Drug: SC amifostine
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SC amifostine (500 mg; two sites; 20 to 60 minutes before irradiation)
Trial: 19263186
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of oral L‐amphetamine sulfate for 29 days
Trial: 23098346
Drug: Losartan 12.5
RxNorm normalized name: losartan 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 12.5 mg
Trial: 10225572
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg tablet
Trial: 8904626
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg tablet
Trial: 8904626
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg solution
Trial: 8904626
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg tablet with food
Trial: 8904626
Drug: 850 mg
RxNorm normalized name: bran 850 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 850 mg tablet fasting
Trial: 1365471
Drug: 2.5% percutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% percutaneous niflumic acid gel applied three times daily for 7 days
Trial: 1365471
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel applied three times daily for 7 days
Trial: 1365471
Drug: Niflumic acid
RxNorm normalized name: niflumic acid
DrugBank: Niflumic acid (DB04552)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niflumic acid gel
Trial: 235939
Drug: Ritodrine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritodrine treatment
Trial: 15937908
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg daily)
Trial: 25306742
Drug: Itopride (Ganaton)
DrugBank: Itopride (DB04924)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itopride (Ganaton) oral tablets 50 mg, 3 times daily for 8 weeks
Trial: 23200288
Drug: Emotion Regulation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Emotion Regulation Training (ERT) + Treatment as Usual (TAU)
Trial: 18252070
Drug: Bio yogurt
RxNorm normalized name: Bio-Kool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio yogurt (150 ml of live strawberry-flavoured yogurt for 12 days)
Trial: 28905166
Drug: Self-help treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-help treatment
Trial: 25995055
Drug: IIH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IIH treatment
Trial: 21707766
Drug: Silodosin (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silodosin (8 mg/daily for a maximum of 8 weeks)
Trial: 21707766
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (drinking 2 L of water daily)
Trial: 19772449
Drug: SC insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SC insulin (regular human insulin or insulin lispro)
Trial: 10905487
Drug: Troglitazone 400
RxNorm normalized name: troglitazone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 400 mg/day
Trial: 11139307
Drug: Amifostine 740
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amifostine 740 mg/m² immediately prior to chemotherapy
Trial: 11139307
Drug: Amifostine with
RxNorm normalized name: Amifostine
DrugBank: Amifostine (DB01143)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amifostine with chemotherapy
Trial: 9722203
Drug: Reinforced regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinforced regimen (6 MU daily for 12 days, 6 MU thrice a week for 22 weeks, 3 MU thrice a week for 24 weeks)
Trial: 7989961
Drug: Subgingival applications
RxNorm normalized name: DOXYCYCLINE 10% SA SUBGINGIVAL SUSP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgingival applications of HPMC membranes containing 20% chlorhexidine and 40% doxycycline, applied twice a week for 6 weeks.